Medytox Files Lawsuit Against Daewoong Pharmaceuticals Over Botox Substance

SEOUL, Oct. 31 (Korea Bizwire) – South Korean pharmaceutical firms Medytox and Daewoong Pharmaceuticals are heading to court to settle a dispute surrounding the use of botulinum toxin, a highly poisonous substance used to make Botox, with the South Korean media branding the legal battle as the ‘Botox War’. According to Medytox on Monday, the pharmaceutical [...]